Novel Benzimidazole Derivatives as Selective CB2 Inverse Agonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|5|298-303

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.5, 2006-01, pp. : 298-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Updating the Chemistry and Biology of Cannabinoid CB2 Receptor- Specific Inverse Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 768-778

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors

By  

Medicinal Chemistry, Vol. 11, Iss. 2, 2015-03 ,pp. : 188-199

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore and 3D-QSAR Studies on 1-Sulfonyl-4-acylpiperazines as Selective Cannabinoid-1 Receptor (CB1R) Inverse Agonists

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 7, 2011-08 ,pp. : 659-670

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents

By  

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3457-3474

Bentham Science Publishers

Access to resources Recommend Favorite